7 min read · Filed under: Foundations, Recovery, Bone Health

Vitamin D3 is the most supplemented vitamin on the planet, and most people taking it are solving half the problem.

D3 increases calcium absorption from the gut. This is its primary physiological function and the reason it matters for bone health — you can't mineralize bone tissue without adequate calcium supply. But absorption is only step one. Calcium that enters your bloodstream needs to be directed somewhere, and without the right molecular machinery, it goes to the wrong places.

This is where vitamin K2 enters, and where the standard "take your D3" advice falls dangerously short. D3 opens the calcium floodgates. K2 tells the calcium where to go. Without K2, you're loading the gun without aiming.

How D3 Actually Works

Vitamin D3 (cholecalciferol) isn't biologically active in the form you swallow. It undergoes two hydroxylation steps — first in the liver (producing 25-hydroxyvitamin D, the form measured in blood tests) and then in the kidneys (producing 1,25-dihydroxyvitamin D, or calcitriol, the active hormone).

Calcitriol enters intestinal epithelial cells and binds to the vitamin D receptor (VDR), a nuclear receptor that acts as a transcription factor. Activated VDR upregulates calcium transport proteins that collectively increase active calcium absorption from your food by two to four-fold.

Without adequate calcitriol, you absorb roughly 10 to 15% of dietary calcium. With adequate calcitriol, 30 to 40%. This is a substantial difference. It's the biological basis for why vitamin D deficiency causes rickets in children and osteomalacia in adults — not a direct effect on bone, but insufficient calcium entering the body.

The problem: D3 increases calcium in the blood. It does not determine where that calcium is deposited.

The K2 Routing System

Vitamin K2 (menaquinone) activates two proteins that together form a calcium routing system.

The first is osteocalcin — produced by osteoblasts (bone-building cells). In its activated (carboxylated) form, osteocalcin binds calcium and incorporates it into the hydroxyapatite crystal matrix of bone tissue. Without K2, osteocalcin remains in its uncarboxylated form — produced but non-functional, unable to direct calcium into bone.

The second is matrix Gla protein (MGP) — produced by vascular smooth muscle cells. MGP's job is the opposite of osteocalcin's: it inhibits calcium deposition in soft tissues. Specifically, activated MGP prevents calcium from crystallizing in arterial walls, heart valves, and kidney tissue. Like osteocalcin, MGP requires K2-dependent carboxylation to function.

The picture is now clear. D3 brings calcium into the bloodstream. K2-activated osteocalcin pulls calcium into bones. K2-activated MGP keeps calcium out of arteries. Without K2, you have elevated serum calcium with no routing — and the calcium deposits where physics and concentration gradients dictate, which includes arterial walls.

This isn't theoretical. The Rotterdam Study found that high K2 intake was associated with a 57% reduction in cardiac mortality, independent of other cardiovascular risk factors. Multiple subsequent studies have confirmed that arterial calcification correlates inversely with K2 status.

The practical implication: supplementing D3 at high doses without K2 may improve bone mineralization while accelerating vascular calcification. You're solving one problem by creating another.

MK-4 vs. MK-7: The K2 Subtypes That Matter

Vitamin K2 is a family of menaquinones. Two forms matter for supplementation.

MK-4 has a short half-life (four to six hours) and reaches high concentrations in the brain, testes, and non-hepatic tissues. Japan has used pharmacological-dose MK-4 (45 mg daily) as an osteoporosis treatment for decades.

MK-7 has a much longer half-life (roughly 72 hours), providing stable blood levels with once-daily dosing. It's the more efficient form for sustained activation of osteocalcin and MGP at nutritional doses. MK-7 is produced by bacterial fermentation — natto (Japanese fermented soybeans) is the richest dietary source.

For daily supplementation alongside D3, MK-7 at 100 to 200 mcg is the practical choice. Consistent K2 activity over 24 hours and the strongest clinical data for both arterial and bone health.

The Latitude Problem — and Why This Matters for the Nomad Lifestyle

Your skin synthesizes vitamin D3 when UVB radiation penetrates the epidermis. But UVB only reaches the surface at sufficient intensity when the solar zenith angle is below approximately 45 degrees. Above roughly 35°N latitude — most of Europe, northern China, Japan, Canada, and the northern US — UVB is insufficient for vitamin D synthesis for significant portions of the year, typically November through March.

If you're based in Southeast Asia, you're in a favorable position — UVB intensity is adequate year-round with adequate sun exposure. But people move. A remote worker who spends January through March in Lisbon (38°N), Berlin (52°N), or London (51°N) isn't synthesizing meaningful D3 from sunlight during those months. Add indoor-dominant lifestyles, SPF use, and air pollution (which filters UVB), and functional D3 deficiency becomes the norm.

This makes supplementation non-optional for anyone living above 35°N for any significant portion of the year — and for many people in equatorial regions who simply don't get adequate unprotected midday sun exposure.

Dosage

Vitamin D3: 2,000 to 5,000 IU daily for maintenance. Higher doses (up to 10,000 IU daily) may be appropriate for correcting deficiency, ideally guided by 25-hydroxyvitamin D blood levels with a target range of 40 to 60 ng/mL. D3 is fat-soluble — take it with a meal containing dietary fat.

Vitamin K2 (as MK-7): 100 to 200 mcg daily. Sufficient to fully carboxylate osteocalcin and MGP in most individuals.

Critical contraindication: Vitamin K directly antagonizes warfarin and other vitamin K antagonist anticoagulants. If you're on warfarin, do not supplement K2 without explicit medical guidance and INR monitoring. This is a pharmacological certainty, not a precautionary disclaimer.

The Honest Frame

D3 and K2 should be co-supplemented by default. There is no scenario where D3 supplementation is appropriate but K2 is not (unless specifically contraindicated by anticoagulant use). The fact that they're still commonly sold separately reflects market inertia rather than science.

For the person who changes cities and hemispheres — adjusting to new latitudes, new sun exposure patterns, new diets — D3+K2 is the baseline supplement. The thing you take regardless of your other goals, adjusted by where you happen to be living this month. It's not exciting. It's structural. And structural compounds are the ones that matter most when you neglect them.

References

1. Geleijnse JM, et al. "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study." Journal of Nutrition, 2004.
2. Knapen MH, et al. "Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women." Thrombosis and Haemostasis, 2015.
3. Holick MF. "Vitamin D deficiency." New England Journal of Medicine, 2007.
4. Masterjohn C. "Vitamin D toxicity redefined: vitamin K and the molecular mechanism." Medical Hypotheses, 2007.
5. van Ballegooijen AJ, et al. "The synergistic interplay between vitamins D and K for bone and cardiovascular health." International Journal of Endocrinology, 2017.